Bio-Surgical Therapy- Overview
DOI:
https://doi.org/10.7439/ijpr.v6i4.3134Abstract
After 21st century William Baer presented a dramatic work to bone and soft tissue infections with live maggots or warm or larva. Certainly numbers of therapists around the globe have rediscovered the benefits of maggot therapy. The principal vision for the in maggot therapy is the clean and clear debridement caused due to chronic wound which are not responding to current antibiotic or antimicrobial therapy. More over the advantage of maggot or warm therapy over existence is low cost, easy production, higher cure rate, lack of resistance and reliable therapy. Modern dressing materials have simplified the procedure and minimized the risk of escaping maggots. The development and establishment of biotech laboratories throughout the world make possible availability to millions of people. Various medical literatures are rapidly growing with scientific evidence demonstrating the efficacy and safety of maggot therapy for a variety of problematic wounds. Current review is prepared to focus various application and advantages of maggot debridement therapy with suitability for choric wounds.
Downloads
References
Olivier, M. How to use the maggot therapy. Proceedings of the 10th International Congress of World Equine Veterinary Association. Jan. 28:2008: 487.
Bexfield, A., Nigam, Y., Thomas, S., Ratcliffe, N.A., Detection and partial characterization of two antibacterial factors from the excretions/secretions of the medicinal maggot Lucilia sericata and their activity against methicillin-resistant Staphylococcus aureus (MRSA). Microbes infect, 2004; 6: 1297-1304.
Ronald, A., S. Maggot Therapy Takes Us Back to the Future of Wound Care: New and Improved Maggot Therapy for the 21st Century. J Diabetes Sci Technol, 2009; 3(2): 336
Finn, G., J
Fenn-Smith, P. Case study: maggot debridement therapy. Wound Practice and Research, 2008; 16(4):169-170.
Steenvoorde, P., Jacobi C.E., Oskam J. Maggot debridement therapy: free-range or contained? An in-vivo study. Adv Skin Wound Care, 2005; 18:430-435.
Casu, R.E., Pearson, R.D., Jamey, J.M,, Cadogan, L.C., Riding, G.A., Tellam, R.L., Excretory / secretory chymotrypsin from Lucilia Cuprina: purification, enzymatic specificity and amino acid sequence deduced from mRNA. Insect Molecular Biology 1994; 3(4): 201- 211.
Daeschlein, G., Mumcuoglu, K.Y., Assadian, O., Hoffmeister, B., Kramer, A. In vitro antibacterial activity of Lucilia sericata maggot secretions. Skin Pharmacol Physiol. 2007; 20(2):112-5.
Tripathi KD. Essentials of Medical Pharmacology. 6th ed. Delhi. Jaypee brother
Patil N.G., Leung G.K. Review article of Maggot debridement therapy in chronic wound care. Hong Kong Med J, 2007; 13:382.
Kate, P., Nicola, H. Maggot therapy use in wound management. NHU Trust, 2012; 2: 3.
Gottrup, F. Maggot debridement: an alternative method for debridement. open access journal of plastic surgery, 2011; 11: 290.
Sherman, R.A., Pechter, E. A. Maggot therapy: a review of the therapeutic applications of fly larvae in human medicine, especially for treating osteomyelitis. Medical and Veterinary Entomology, 1988; 2: 225-230.
Thomas, S., Jones, M. The use of sterile maggots in wound management. Wound Care Society, 1999;6(4).22-30.
Thomas, S., Andrews, A., Jones, M. The use of larval therapy in wound management. Journal of Wound Care. 1998; 7(10): 521-524.
Sherman, A.R. Maggot versus conservative debridement therapy for the treatment of pressure ulcers. Wound repair and regeneration, 2002; 10: 209.
Sherman, A.R., Wyle, F., Vulpe, M., Maggot therapy for treating pressure ulcer in spinal cord injury patients. Journal of spinal cord medicine, 1995; 18: 71.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- Author must Submit Copyright form After acceptance of Article
How to Cite
